Literature DB >> 29850191

Prognostic factors of patients with pathologic stage I lung adenocarcinoma.

Ying-Yi Chen1, Tsai-Wang Huang1.   

Abstract

Entities:  

Year:  2018        PMID： 29850191      PMCID： PMC5949440          DOI： 10.21037/jtd.2018.04.37

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  37 in total

1.  Spread through air spaces is a predictive factor of recurrence and a prognostic factor in stage I lung adenocarcinoma.

Authors:  Satoshi Shiono; Naoki Yanagawa
Journal:  Interact Cardiovasc Thorac Surg       Date:  2016-06-26

2.  Pathological prognostic factors of recurrence in early stage lung adenocarcinoma.

Authors:  Eunjue Yi; Mi-Kyeong Bae; Sukki Cho; Jin-Haeng Chung; Sanghoon Jheon; Kwhanmien Kim
Journal:  ANZ J Surg       Date:  2017-07-12       Impact factor: 1.872

3.  Positron emission tomography for predicting recurrence in stage I lung adenocarcinoma: standardized uptake value corrected by mean liver standardized uptake value.

Authors:  Satoshi Shiono; Masami Abiko; Toshimasa Okazaki; Masato Chiba; Hiroshi Yabuki; Toru Sato
Journal:  Eur J Cardiothorac Surg       Date:  2011-04-19       Impact factor: 4.191

4.  Micropapillary pattern: a distinct pathological marker to subclassify tumours with a significantly poor prognosis within small peripheral lung adenocarcinoma (</=20 mm) with mixed bronchioloalveolar and invasive subtypes (Noguchi's type C tumours).

Authors:  Y Makimoto; K Nabeshima; H Iwasaki; T Miyoshi; S Enatsu; T Shiraishi; A Iwasaki; T Shirakusa; M Kikuchi
Journal:  Histopathology       Date:  2005-06       Impact factor: 5.087

5.  Lepidic and micropapillary growth pattern and expression of Napsin A can stratify patients of stage I lung adenocarcinoma into different prognostic subgroup.

Authors:  Xin Yang; Yu Liu; Fang Lian; Lei Guo; Peng Wen; Xiu-Yun Liu; Dong-Mei Lin
Journal:  Int J Clin Exp Pathol       Date:  2014-03-15

6.  Histopathological features and prognostic significance of the micropapillary pattern in lung adenocarcinoma.

Authors:  Kazunori Kamiya; Yuichiro Hayashi; Junya Douguchi; Akinori Hashiguchi; Taketo Yamada; Yotaro Izumi; Masazumi Watanabe; Masafumi Kawamura; Hirohisa Horinouchi; Naoki Shimada; Koichi Kobayashi; Michiie Sakamoto
Journal:  Mod Pathol       Date:  2008-05-30       Impact factor: 7.842

7.  Elevated nuclear CCND1 expression confers an unfavorable prognosis for early stage lung adenocarcinoma patients.

Authors:  Ping Xu; Mengyang Zhao; Zhen Liu; Yiyi Liu; Yiyu Chen; Rongcheng Luo; Weiyi Fang
Journal:  Int J Clin Exp Pathol       Date:  2015-12-01

8.  Thyroid transcription factor 1 is an independent prognostic factor for patients with stage I lung adenocarcinoma.

Authors:  Valsamo K Anagnostou; Konstantinos N Syrigos; Gerold Bepler; Robert J Homer; David L Rimm
Journal:  J Clin Oncol       Date:  2008-12-08       Impact factor: 44.544

9.  Carcinoembryonic antigen as a predictive factor for postoperative tumor relapse in early-stage lung adenocarcinoma.

Authors:  Yukinori Sakao; Shinji Tomimitsu; Yuji Takeda; Masafumi Natsuaki; Tsuyoshi Itoh
Journal:  Eur J Cardiothorac Surg       Date:  2004-04       Impact factor: 4.191

10.  Two-gene signature improves the discriminatory power of IASLC/ATS/ERS classification to predict the survival of patients with early-stage lung adenocarcinoma.

Authors:  Yifeng Sun; Likun Hou; Yu Yang; Huikang Xie; Yang Yang; Zhigang Li; Heng Zhao; Wen Gao; Bo Su
Journal:  Onco Targets Ther       Date:  2016-07-25       Impact factor: 4.147
View more
  1 in total

1.  Lymph node micrometastasis in N stage: a call for more evidence.

Authors:  Yijiu Ren; Chenyang Dai; Huikang Xie; Yunlang She; Hang Su; Chang Chen
Journal:  J Thorac Dis       Date:  2018-07       Impact factor: 2.895
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.